Skip to main content
OpenTrials
Completed

NCT Number: NCT07138170

Distal vs Conventional Transradial Access for Coronary Procedures

Background: Radial artery occlusion (RAO) is a recognized complication of transradial coronary access, with reported incidence rates ranging from 5% to 30%. Distal radial access (DRA), performed at the anatomical snuffbox, has emerged as a promising alternative that may better preserve radial artery patency by maintaining antegrade perfusion through the palmar arch during hemostasis.

Objective: To compare distal radial access with conventional transradial access in terms of radial artery patency and access-site outcomes in a real-world all-comers population undergoing coronary angiography or percutaneous coronary intervention.

Methods: This prospective, multicenter, open-label, quasi-randomized comparative study enrolled 350 patients across three community-based hospitals in Palestine and Jordan between 2024 and 2026. Patients were allocated in a 1:1 ratio to DRA (n=183) or conventional transradial access (n=167) using an alternating sequence. The primary endpoint was radial artery patency assessed by blinded duplex ultrasonography at 24 hours and at 1 to 6 months. Secondary endpoints included access-site pain, bruising, numbness, and crossover to an alternative access site. The 24-hour outcome was analyzed by intention-to-treat and long-term outcomes by per-protocol analysis. Adjusted analyses used Firth penalized logistic regression.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Specialty Hospital

Amman, Shmeisani, Jordan

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age ≥ 18 years
  • Undergoing diagnostic coronary angiography or percutaneous coronary intervention via an intended radial approach
  • Palpable radial pulse at the intended puncture site
  • Able to provide written or verbal informed consent
  • No contraindication to radial artery access at the intended site, as determined by the treating operator

Exclusion criteria

  • Age < 18 years
  • Inability to provide informed consent
  • Absent or non-palpable radial pulse at the intended access site
  • Active pregnancy
  • Medical condition likely to cause non-compliance with the study protocol or confound data interpretation

Treatment and study plan

Conventional Transradial Artery Access

Procedure

Using Conventional Transradial Artery Access for Cardiac Catheterization

Distal radial artery access

Procedure

Using Distal Radial Artery access for Cardiac Catheterization

Primary outcomes

  1. Radial artery occlusion (RAO) assessed by duplex ultrasonography

    Time frame: 24 hours and 1-6 months post procedure

    Radial artery occlusion defined as absence of antegrade flow on duplex ultrasonography, assessed within 24 hours and at 1-6 months after the procedure.

Secondary outcomes

  1. Access-Site Pain

    Time frame: 24 hours and 1-6 months post-procedure.

    The patients will be asked to rate their pain on a 1-10 scale.

  2. Crossover to Alternative Access Site

    Time frame: At the time of procedure

    In cases where radial access is unsuccessful, crossover to an alternative access site, such as the contralateral radial or femoral artery, will be documented

  3. Access-Site Numbness

    Time frame: 24 hours and 1-6 months post-procedure

    Number of participants with numbness at the access site assessed by physical examination.

  4. Access-Site Bruising

    Time frame: 24 hours and 1-6 months post-procedure

    Number of participants with bruising at the access site assessed by physical examination.

Sponsors and collaborators

Lead sponsor

Jordanian Research and Artificial Intelligence Group

Other

Registry information

Official study title

Comparison of Distal and Conventional Transradial Access for Coronary Catheterization: A Multicenter, Quasi-Randomized Study

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Aug 22, 2025
Registry last updated
May 11, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.